Grasberg On Track, Yet FCX Valuation Leaves Little Margin

What happened

A Seeking Alpha article claims Freeport-McMoRan is undervalued relative to copper, with the stock pricing in about $5.70 copper, and points to Grasberg running slightly ahead of its revised plan with capacity targets reaffirmed. However, the DeepValue master report rates FCX a WAIT, noting the stock at $68.20 already discounts a favorable blend of high copper and improving Grasberg operations. The report's base case implied value is $66, below the article's $85 target, with the bull case at $78. Management guidance still calls for PTFI to reach about 80% capacity by mid-2027 and only approach full capacity by end-2027, indicating the recovery is back-end loaded. The discrepancy reflects different assumptions: the article uses a 7.0x EV/EBITDA multiple on 2027/28 EBITDA at $6.50 copper, while the master report emphasizes execution risk and current cost headwinds.

Implication

The modestly positive Grasberg update is already reflected in FCX's valuation, leaving little room for error. Until FCX delivers Q3 2026 copper sales at or above the 750 million pound guide and shows falling Indonesia idle facility costs, the stock remains vulnerable to any copper price pullback or operational disappointment. The prudent approach is to hold existing positions but avoid adding at current levels; trim near $75 if the stock runs on price strength alone. Attractive entry remains near $58, where the risk-reward improves with a margin of safety against execution setbacks. Continued monitoring of COMEX-LME spreads and unit cost trends is essential before upgrading the rating.

Thesis delta

The news that Grasberg is back on schedule does not alter the core thesis that FCX is fully valued at current levels. While it modestly reduces the risk of further delays, it does not provide the operating proof required to shift from WAIT to BUY. The attractive entry remains near $58, and the trim level near $75 is unchanged.